Brought to you by:
VasQ AVF creation device receives FDA clearance
Laminate Medical Technologies has announced their flagship device, the VasQ external vascular support, has been cleared by the Food and Drug Administration (FDA) for use to create arteriovenous fistulas (AVFs) for dialysis access. The device, designated by the FDA as…
EndoAVF found usually less cost effective compared with sAVF
The Society for Clinical Vascular Surgery (SCVS) 50th Annual Symposium (25–29 March, Miami) hosted a series of abstract presentations. Among them was one by Bianca Mulaney, MD and colleagues including Elizabeth George, MD, Stanford University, Stanford, on the cost effectiveness…
Amplifi vein dilation system continues to show promise following latest first-in-human study update
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of Medicine in St Louis, during the first-ever late-breaking clinical trials session at this year’s Venous Endovascular…
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to a patient’s race said the findings speak “to an injustice within the field of vascular surgery.” The research…
Registry data highlight long-term trends in hemodialysis access profile of failed kidney transplant patients
New findings, recently published in the Journal of Vascular Access (JVA), provide insight into the hemodialysis access profile of failed kidney transplant patients treated in the Catalonia region of Spain over an 18-year period. Researchers Ramon Roca-Tey, MD, a senior…
Houston, we have a dialysis access problem
The concept of dedicated vascular access centers fuels a turbocharged Texan tussle with Karl Illig, MD, of Flow Vascular Institute in Houston, taking on Eric Peden, MD, an associate professor of cardiovascular surgery at Houston Methodist Hospital, in a no-holds-barred debate…
Amplifi vein dilation system demonstrates ‘encouraging’ clinical results in hemodialysis access
Artio Medical announced that full results from its first-in-human clinical study of the Amplifi vein dilation system were presented at the 2021 VEITHSymposium (Nov. 16–20, Orlando) by Surendra Shenoy, MD, associate professor of surgery in the Washington University School of…
IN.PACT AV DCB sustained ‘superior’ effectiveness in subgroups with high reintervention rates out to two years
Several subgroups of patients treated with the IN.PACT AV drug-coated balloon (DCB) for arteriovenous fistulas (AVFs) demonstrated a “statistically significant” higher rate of target lesion primary patency (TLPP) compared to those who underwent standard percutaneous transluminal angioplasty (PTA) through 24…
First-in-human study of Wrapsody endoprosthesis yields ‘very promising’ results
Merit Medical Systems has announced positive results from a prospective, observational, first-in-human study to evaluate the safety and effectiveness of Wrapsody—a self-expanding, cell-impermeable endoprosthesis designed for the treatment of arteriovenous (AV) fistula access circuit stenosis and AV graft access circuit…
CMS creates new billing code for central venous vascular access system
Bluegrass Vascular Technologies announced today that the Centers for Medicare & Medicaid Services (CMS) has finalized a new Healthcare Common Procedure Coding System (HCPCS) code and New Technology Ambulatory Payment Classification (APC) assignment for use of the Surfacer Inside-Out Access…